Bioethicist challenges Bachmann on vaccine claim

Students with symptoms of sleep disorders are more likely to receive bad grades in classes such as math, reading and writing than peers without symptoms of sleep disorders, according to a research abstract that will be presented ...

In an article appearing in the current issue of Clinical Pharmacology & Therapeutics, experts from the University of Pennsylvania Center for Bioethics and Johns Hopkins Berman Institute of Bioethics review the controversy surrou ...

A new Phase I clinical trial sponsored by the Vermont Cancer Center at the University of Vermont and Fletcher Allen Health Care has opened to test the investigational drug DFMO, or alpha-difluoromethylornithine, as a treatment ...

(PhysOrg.com) -- In a new study published in Lancet, researchers from Australia report evidence that the vaccine designed to target the human papillomavirus, or HPV, has dramatically dropped the incidence of les ...

Less than two years after the HPV vaccine was approved as a routine vaccination for girls aged 11 and older, one-quarter of California adolescent girls have started the series of shots that protect against human papillomavirus, ...

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

A social media push boosted the number of people who registered themselves as organ donors 21-fold in a single day, Johns Hopkins researchers found, suggesting social media might be an effective tool to address the stubborn ...

A Yale project involving the independent review of a bone growth product's safety has yielded results, which are published in the June 18 issue of Annals of Internal Medicine. The findings are part of the Yale University Open D ...

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

(AP)—The plans of a former Microsoft manager to create the "Starbucks of Pot" are worrying other activists who pushed for the legalization of marijuana in Washington state.